SEC Form 4 · accession 0001179110-17-013345
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
Oct 16, 2017
Accepted (ET)
Oct 18, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 16, 2017 | S | 25,000 | $32.37 | D | 20,887 | D | |
| Common StockF3 | Oct 17, 2017 | S | 10,000 | $34.03 | D | 10,887 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017.
- F2Represents the weighted average price of transactions ranging from $31.45 to $32.78. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average price of transactions ranging from $34.00 to $34.15. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.